TRAVERE THERAPEUTICS, INC. Public Float
TRAVERE THERAPEUTICS, INC. (TVTX) had Public Float of $1.31 billion as of 2025-06-30, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-19
- 2025-06-30: Entity Public Float $1.31B.
- 2024-06-30: Entity Public Float $624.14M.
- 2023-06-30: Entity Public Float $1.15B.
- 2022-06-30: Entity Public Float $1.54B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $1.31B 10-K · filed 2026-02-19 |
| 2024-06-30 | $624.14M 10-K · filed 2025-02-21 |
| 2023-06-30 | $1.15B 10-K · filed 2024-02-20 |
| 2022-06-30 | $1.54B 10-K · filed 2023-02-23 |
| 2021-06-30 | $879.38M 10-K · filed 2022-02-24 |
| 2020-06-30 | $1.03B 10-K · filed 2021-03-01 |
| 2019-06-30 | $853.24M 10-K · filed 2020-02-24 |
| 2018-06-30 | $912.69M 10-K · filed 2019-02-26 |
| 2017-06-30 | $661.87M 10-K · filed 2018-07-06 |
| 2016-06-30 | $576.73M 10-K · filed 2017-03-01 |
| 2015-06-30 | $1.15B 10-K · filed 2016-02-26 |
| 2014-06-30 | $120.83M 10-K · filed 2015-03-11 |
| 2013-09-13 | $0.00 10-K/A · filed 2013-09-16 |
| 2013-06-30 | $41.99M 10-K/A · filed 2015-07-09 |
| 2013-05-30 | $0.00 10-K · filed 2013-06-13 |
| 2012-08-31 | $16.79K 10-Q · filed 2012-10-10 |
| 2012-05-31 | $16.79K 10-Q · filed 2012-08-08 |
| 2012-02-29 | $16.79K 10-K · filed 2012-05-24 |
| 2011-08-31 | $151.09K 10-Q/A · filed 2012-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |